Puma Biotechnology | PBYI - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amgen USD 189.89B 13.64B 2026-03
Biogen USD 26.9B 1.09B 2026-03
BioMarin Pharmaceutical USD 10.57B 290M 2026-05
Daiichi Sankyo JPY 6.34T 62.51B 2025-12
Esperion Therapeutics USD 885M 351M 2025-12
Exelixis USD 12.9B 1.15B 2026-05
Gilead Sciences USD 152.28B 14.55B 2025-12
Incyte USD 21.73B 3B 2026-05
MacroGenics USD 102M 4M 2025-12
Moderna USD 20.15B 8.53B 2026-03
Novartis USD 232.75B 75B 2026-05
Pfizer USD 148.08B 6.51B 2026-05
PTC Therapeutics USD 6.1B 1.22B 2025-12
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Takeda JPY 7.64T 774.9B 2025-12
TG Therapeutics USD 4.73B 1B 2025-12
Ultragenyx Pharmaceutical USD 2.04B 176M 2026-05
Vanda Pharmaceuticals USD 279M 6M 2024-12
Vertex Pharmaceuticals USD 111.03B 2.55B 2026-05